Cellectis
Data Breaches, Cyber Attacks and Security Report

https://cellectis.com  ᛫  Biotech & Pharmaceuticals
Last updated March 21, 2020

Cellectis Security Rating

${grade.letter}
${cstarScore}
/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Cellectis is implementing good security practices.

Company Information

Company:
${companyName}
Valuation:
${marketCap}
Employees:
${employees}
Location:
${country}
CEO:
${ceo}

About Cellectis

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.


Data Breaches and Security News


Security Report for Cellectis

Want a security rating for your organization?

This report shows a preliminary security rating for Cellectis. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Cellectis's security performance with other companies